View in EDS HTML Full Text PDF Full Text

Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.

Saved in:
Bibliographic Details
Title: Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
Authors: Ferro C; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland., Matos AI; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal., Serpico L; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands., Fontana F; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland., Chiaro J; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland., D'Amico C; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland., Correia A; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland., Koivula R; Department of Chemistry, University of Helsinki, Helsinki, FI-00014, Finland., Kemell M; Department of Chemistry, University of Helsinki, Helsinki, FI-00014, Finland., Gaspar MM; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal., Acúrcio RC; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal., Cerullo V; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, FI-00014, Finland., Santos HA; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands., Florindo HF; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
Source: Advanced healthcare materials [Adv Healthc Mater] 2025 Feb; Vol. 14 (5), pp. e2401523. Date of Electronic Publication: 2024 Aug 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659 (Electronic) Linking ISSN: 21922640 NLM ISO Abbreviation: Adv Healthc Mater Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39205539
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferro+C%22">Ferro C</searchLink>; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Matos+AI%22">Matos AI</searchLink>; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.<br /><searchLink fieldCode="AU" term="%22Serpico+L%22">Serpico L</searchLink>; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Fontana+F%22">Fontana F</searchLink>; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Chiaro+J%22">Chiaro J</searchLink>; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22D'Amico+C%22">D'Amico C</searchLink>; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Correia+A%22">Correia A</searchLink>; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Koivula+R%22">Koivula R</searchLink>; Department of Chemistry, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Kemell+M%22">Kemell M</searchLink>; Department of Chemistry, University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Gaspar+MM%22">Gaspar MM</searchLink>; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.<br /><searchLink fieldCode="AU" term="%22Acúrcio+RC%22">Acúrcio RC</searchLink>; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.<br /><searchLink fieldCode="AU" term="%22Cerullo+V%22">Cerullo V</searchLink>; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, FI-00014, Finland.<br /><searchLink fieldCode="AU" term="%22Santos+HA%22">Santos HA</searchLink>; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Florindo+HF%22">Florindo HF</searchLink>; Research Institute for Medicines, iMed.Ulisboa, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, 1649-003, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101581613%22">Advanced healthcare materials</searchLink> [Adv Healthc Mater] 2025 Feb; Vol. 14 (5), pp. e2401523. <i>Date of Electronic Publication: </i>2024 Aug 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH%22">Wiley-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101581613 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2192-2659 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221922640%22">21922640 </searchLink><i>NLM ISO Abbreviation: </i>Adv Healthc Mater <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39205539
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/adhm.202401523
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2401523
    Titles:
      – TitleFull: Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferro C
      – PersonEntity:
          Name:
            NameFull: Matos AI
      – PersonEntity:
          Name:
            NameFull: Serpico L
      – PersonEntity:
          Name:
            NameFull: Fontana F
      – PersonEntity:
          Name:
            NameFull: Chiaro J
      – PersonEntity:
          Name:
            NameFull: D'Amico C
      – PersonEntity:
          Name:
            NameFull: Correia A
      – PersonEntity:
          Name:
            NameFull: Koivula R
      – PersonEntity:
          Name:
            NameFull: Kemell M
      – PersonEntity:
          Name:
            NameFull: Gaspar MM
      – PersonEntity:
          Name:
            NameFull: Acúrcio RC
      – PersonEntity:
          Name:
            NameFull: Cerullo V
      – PersonEntity:
          Name:
            NameFull: Santos HA
      – PersonEntity:
          Name:
            NameFull: Florindo HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2192-2659
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Advanced healthcare materials
              Type: main
ResultId 1